Could anti-CD20 therapy jeopardise the efficacy of a SARS-CoV-2 vaccine?
Roch Houot, Ronald Levy, Guillaume Cartron, Philippe Armand
Topics & Concepts
MedicinePandemicSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Coronavirus disease 2019 (COVID-19)CD202019-20 coronavirus outbreakVirologyIntensive care medicineImmunologyInternal medicineAntigenDiseaseInfectious disease (medical specialty)OutbreakSARS-CoV-2 and COVID-19 ResearchCOVID-19 and healthcare impactsCOVID-19 Clinical Research Studies